Publications in collaboration with researchers from New York University School of Medicine (17)

2021

  1. 5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia

    Journal of the European Academy of Dermatology and Venereology

  2. A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)

    JAMA Dermatology, Vol. 157, Núm. 4, pp. 439-448

  3. Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients

    Journal of the European Academy of Dermatology and Venereology

  4. Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster

    Medical Hypotheses, Vol. 146

  5. Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men

    Journal of the European Academy of Dermatology and Venereology

  6. Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)*

    British Journal of Dermatology, Vol. 185, Núm. 6, pp. 1221-1231

  7. Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial

    Frontiers in Medicine, Vol. 8

  8. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients

    Journal of the American Academy of Dermatology, Vol. 84, Núm. 6, pp. 1644-1651

  9. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management

    JAAD International, Vol. 5, pp. 11-18